Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China
Crossref DOI link: https://doi.org/10.1007/s40261-016-0486-8
Published Online: 2016-12-07
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Keng
Zhang, Chi
Ke, Weixia
Gao, Yanhui
Zhou, Shudong
Liu, Li
Yang, Yi
Funding for this research was provided by:
National Natural Science Foundation of China (71573059)
License valid from 2016-12-07